Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlycoMimetics Inc (NASDAQ:GLYC)

11.50
Delayed Data
As of Jul 21
 -0.33 / -2.79%
Today’s Change
3.82
Today|||52-Week Range
16.94
+88.52%
Year-to-Date
No recent news for GlycoMimetics Inc.

Today’s Trading

Previous close11.83
Today’s open11.78
Day’s range11.46 - 11.96
Volume200,440
Average volume (3 months)1,864,473
Market cap$354.8M
Dividend yield--
Data as of 4:00pm ET, 07/21/2017

Growth & Valuation

Earnings growth (last year)-123.88%
Earnings growth (this year)+5.00%
Earnings growth (next 5 years)--
Revenue growth (last year)-99.91%
P/E ratioNM
Price/Sales7,008.84
Price/Book7.57

Competitors

 Today’s
change
Today’s
% change
AQXPAquinox Pharmaceutic...-0.01-0.07%
RARXRa Pharmaceuticals I...+0.02+0.13%
COLLCollegium Pharmaceut...+0.33+2.66%
ZGNXZogenix Inc-0.20-1.47%
Data as of 4:00pm ET, 07/21/2017

Financials

Next reporting dateAugust 4, 2017
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$18.5K
Annual profit (last year)-$31.8M
Net profit margin-171,945.07%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Rachel K. King
Chief Financial Officer
Brian M. Hahn
Corporate headquarters
Rockville, Maryland

Forecasts